RadNet, Inc.
Health
Performance
5.4
Risk
Sell
Buy
Curious about the Scores? Learn more.

RadNet, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.01.2026
Back on its feet. Fundamentals looking less chaotic.
14.01.2026
Still winning, but momentum’s cooling a bit.
20.11.2025
Signs of control returning. Still shaky, but not chaos.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

RadNet, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does RadNet, Inc. do? Business model and key facts

Get the full picture of RadNet, Inc.: what it builds, where it operates, and how it makes money.

RadNet, Inc. Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 11000

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

shop
Company facts
Howard G. Berger
CEO
11000
Employees worldwide
shop
Performance
18.22%
Last 12 months
254.84%
Last 5 years
shop
Growth
$1,83B
Revenue year
$38,84M
Net income
shop
Valuation
$5,64B
Market Cap
1826.32
Price/Earnings Ratio

Stocks related to RadNet, Inc.

Selected based on industry alignment and relative market positioning.

QGEN
Qiagen N.V.
47.31
+0.65%
3.4
Sell
Buy
Qiagen N.V.
CRL
Charles River Laboratories International, Inc.
224.91
+0.64%
7.0
Sell
Buy
Charles River Laboratories International, Inc.
RVTY
Revvity, Inc.
112.22
-2.70%
4.6
Sell
Buy
Revvity, Inc.
SHC
Sotera Health Company
19.19
-0.83%
5.2
Sell
Buy
Sotera Health Company
GRAL
GRAIL, Inc.
99.90
+2.52%
9.3
Sell
Buy
GRAIL, Inc.

RadNet, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.